Biomarker May Predict Prostate Cancers Requiring Treatment

Researchers have now identified a 3-gene signature that could indicate whether a particular early-stage prostate cancer is indolent. The test relies on a tissue sample, a PSA test, and a histology assessment.
Source: Cancer Network - Category: Cancer & Oncology Source Type: news